2 terminated, 1 completed, 1 not yet recruiting, 1 recruiting. 5 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 5 | Terminated 2, Completed 1, Not yet recruiting 1, Recruiting 1 |
Follow seladelpar: new trials by email Literature Review of seladelpar trials Research Report on seladelpar
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of Seladelpar and Cilofexor in Participants With Primary Biliary Cholangitis Seladelpar, PTM Seladelpar, Cilofexor Dose B - Primary Biliary Cholangitis | Phase 2 | Recruiting | Gilead Sciences | 132 | 2026-10-01 | 2026-10-27 |
| Seladelpar in Adult Liver Transplant Recipients With Ischemic Cholangiopathy (SELIC). Seladelpar - Liver Transplant; Complications, Ischemic Cholangiopathy | Phase 2 | Not yet recruiting | University of California, San Diego | 10 | 2026-05-01 | 2026-04-09 |
| A Study to Evaluate the Safety, and Tolerability, and Efficacy of Seladelpar in Patients With PSC Seladelpar, Placebo to match Seladelpar - Primary Sclerosing Cholangitis | Phase 2 | Terminated | Gilead Sciences | 1 | 2019-11-12 | 2025-01-16 |
| A Study to Evaluate Seladelpar in Subjects With Nonalcoholic Steatohepatitis (NASH) Seladelpar, Placebos - NASH - Nonalcoholic Steatohepatitis | Phase 2 | Terminated | Gilead Sciences | 181 | 2018-04-30 | 2022-09-15 |
| Seladelpar (MBX-8025) in Subjects With Primary Biliary Cholangitis (PBC) MBX-8025 2 mg Capsule, MBX-8025 5 mg Capsule, MBX-8025 10 mg Capsule - Primary Biliary Cirrhosis | Phase 2 | Completed | Gilead Sciences | 119 | 2016-11-28 | 2022-07-14 |
Liver Cirrhosis, Biliary (2) · Bile Duct Diseases (1) · Biliary Tract Diseases (1) · Cholangitis (1) · Cholangitis, Sclerosing (1) · Digestive System Diseases (1) · Non-alcoholic Fatty Liver Disease (1)
Gilead Sciences (4) · University of California, San Diego (1)
United States (4) · Canada (2) · Germany (1) · Poland (1) · United Kingdom (1)
PMID 33793651, PMID 35367282, PMID 39326675
2019 (1)